Literature DB >> 53266

Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex.

T G Rehn, G M Shearer, H S Koren, J K Inman.   

Abstract

Splenic lymphocytes from four C57BL/10 congenic mouse strains were sensitized in vitro to N(-3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-alanylglycylglycyl-(N) modified autologous lymphocytes. The effector cells generated after 5 days of culture were assayed on a series of either N-modified phytohemagglutinin-stimulated spleen cells or N-modified tumor cells. The results indicated in all cases that both N modification of the targets and H-2 homology between the modified stimulating and target cells are required for lysis to occur. In each case the effector cells were found to lyse N-modified target cells only when there was homology at either or both ends of the major histocompatibility complex (MHC) between the stimulator and target cells. B10.BR lysed targets sharing alleles at K (or K plus I-A) and/or at D. B10.A effector cell specificity was mapped to K (or K plus I-A) and/or the D half of the MHC (D or D plus I-C and/or S). The two regions of specificity determined for B10.D2 effector cells were D (or D plus S plus I-C) and a region not including D of the MHC. C57BL/10 effector cells lysed N-modified targets only if there was target cell H-2 homology at K, I-A, and I-B or at the D serological region. As in the trinitrophenyl (TNP) system (6) B10.BR and B10.A effector cells lysed targets sharing K end H-2 serological regions greater than target cells sharing D-end serological regions. The C57BL/10 effector cells were shown to react to the K end greater than the D end, which differed from the equal reactivity seen in the TNP system for this strain. The data are consistent with the hypothesis that the antigen recognized by the effector cell includes an altered H-2 serological cell surface product. That the reaction is not "hapten specific" and the H-2 homology is required only for effector:target cell interaction was excluded by the use of two F1 combinations in which lysis of only N-modified target cells sharing the H-2 haplotype with the stimulating parental strain was obtained. Finally, it was demonstrated that N and TNP modification create distinct new antigenic determinants, since an effector cell sensitized to one modifying agent will lyse only H-2 matched target modified with that same modifying agent.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 53266      PMCID: PMC2190097          DOI: 10.1084/jem.143.1.127

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.

Authors:  U Koszinowski; H Ertl
Journal:  Nature       Date:  1975-06-12       Impact factor: 49.962

2.  Coupling of large haptens to proteins and cell surfaces: preparation of stable, optimally sensitized erythrocytes for hapten-specific, hemolytic plaque assays.

Authors:  J K Inman; B Merchant; L Claflin; S E Tacey
Journal:  Immunochemistry       Date:  1973-03

3.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

4.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

5.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

6.  Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.

Authors:  I Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

7.  Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex.

Authors:  I D Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.

Authors:  J Forman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

9.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.

Authors:  P C Doherty; R M Zinkernagel
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  8 in total

1.  Secondary in vitro responses of T lymphocytes to non-H-2 alloantigens self-H-2-restricted responses induced in heterologous serum are not dependent on primary-stimulating non-H-2 alloantigens.

Authors:  A B Peck; L C Andersson; H Wigzell
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

2.  Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

Authors:  J H Russell; A H Hale; L C Ginns; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.

Authors:  S Kunin; R Gallily
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

4.  The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. I. Synthesis of a novel haptenic MDP derivative cross-reactive with Bacillus Calmette Guerin and its application to enhanced induction of tumor immunity.

Authors:  T Hamaoka; Y Takai; A Kosugi; Y Mizushima; J Shima; T Kusama; H Fujiwara
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.

Authors:  P A Henkart; M Schmitt-Verhulst; G M Shearer
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

6.  Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds.

Authors:  T G Rehn; J K Inman; G M Shearer
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

7.  Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.

Authors:  A M Schmitt-Verhulst; G M Shearer
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

8.  H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteins.

Authors:  A M Schmitt-Verhulst; C B Pettinelli; P A Henkart; J K Lunney; G M Shearer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.